Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma
Titel:
Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma
Auteur:
Hari, Parameswaran Paba-Prada, Claudia E. Voorhees, Peter M. Frye, John Chang, Yu-Lin Moreau, Philippe Zonder, Jeffrey Boccia, Ralph Shain, Kenneth H.